VS-214
/ Vasa Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 05, 2026
VS-214: A First-in-Class Long-Acting Apelin Agonist with Exercise-Mimetic Potential for Peripheral Artery Disease
(AHA 2026)
- No abstract available
Cardiovascular • Peripheral Arterial Disease
1 to 1
Of
1
Go to page
1